Bernard R. Chaitman
Department of Medicine
Saint Louis University School of Medicine
St Louis
Missouri 63117
USA
Name/email consistency: high
- Choice of initial medical therapy vs. prompt coronary revascularization in patients with type 2 diabetes and stable ischemic coronary disease with special emphasis on the BARI 2D trial results. Chaitman, B.R., Hadid, M., Laddu, A.A. Curr. Opin. Cardiol. (2010)
- The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Chaitman, B.R., Hardison, R.M., Adler, D., Gebhart, S., Grogan, M., Ocampo, S., Sopko, G., Ramires, J.A., Schneider, D., Frye, R.L. Circulation (2009)
- Should ECG be required in young athletes?. Chaitman, B.R., Fromer, M. Lancet (2008)
- Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease. Chaitman, B.R., Sano, J. Clin. Cardiol (2007)
- An electrocardiogram should not be included in routine preparticipation screening of young athletes. Chaitman, B.R. Circulation (2007)
- Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Chaitman, B.R. Circulation (2006)
- When should ranolazine be considered for the treatment of chronic angina?. Chaitman, B.R. Nature Clinical Practice. Cardiovascular Medicine (2006)
- Antianginal efficacy of omapatrilat in patients with chronic angina pectoris. Chaitman, B.R., Ivleva, A.Y., Ujda, M., Lenis, J.H., Toth, C., Stieber, D.M., Reisin, L.H., Pangerl, A.M., Friedman, J.B., Lawrence, J.H. Am. J. Cardiol. (2005)
- Pharmacological approaches to the symptomatic treatment of chronic stable angina: a historical perspective and future directions. Chaitman, B.R. Can. J. Cardiol (2005)
- Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. Chaitman, B.R., Pepine, C.J., Parker, J.O., Skopal, J., Chumakova, G., Kuch, J., Wang, W., Skettino, S.L., Wolff, A.A. JAMA (2004)
- Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. Chaitman, B.R., Skettino, S.L., Parker, J.O., Hanley, P., Meluzin, J., Kuch, J., Pepine, C.J., Wang, W., Nelson, J.J., Hebert, D.A., Wolff, A.A. J. Am. Coll. Cardiol. (2004)
- Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials. Chaitman, B.R. J. Cardiovasc. Pharmacol. Ther. (2004)
- A review of the GUARDIAN trial results: clinical implications and the significance of elevated perioperative CK-MB on 6-month survival. Chaitman, B.R. J. Card. Surg (2003)
